Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy

被引:7
作者
Slart, R. H. J. A. [1 ,4 ]
Tio, R. A. [2 ,4 ]
van der Vleuten, P. A. [2 ]
Willems, T. P. [3 ]
Lubbers, D. D. [3 ]
Dierckx, R. A.
van Veldhuisen, D. J. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9700 RB Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands
[4] Univ Med Ctr Groningen, Cardiovasc Imaging Grp Groningen, NL-9713 AV Groningen, Netherlands
关键词
Left ventricular function; cardiomyopathy; PET imaging; magnetic resonance imaging; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; BLOOD-FLOW; EJECTION FRACTION; PROGNOSTIC VALUE; PET; IMPROVEMENT; METOPROLOL; ISCHEMIA;
D O I
10.1007/s12350-010-9216-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In Idiopathic Dilated Cardiomyopathy (IDC) an imbalance between myocardial oxygen consumption and supply has been postulated. The ensuing subclinical myocardial ischemia may contribute to progressive deterioration of LV function. beta-blocker is the therapy of choice in these patients. However, not all patients respond to the same extent. The aim of this study was to elucidate whether differences between responders and non-responders can be identified with respect to regional myocardial perfusion reserve (MPR) and contractile performance. Patients with newly diagnosed IDC underwent Positron Emission Tomography (PET) scanning using both (13)N-ammonia as a perfusion tracer (baseline and dipyridamole stress), and (18)F-fluoro-deoxyglucose as a metabolism tracer, and a dobutamine stress MRI. MRI and PET were repeated 6 months after maximal beta-blocker therapy. MPR (assessed by PET) as well as wall motion score (WMS, assessed by MRI) were evaluated in a 17 segment-model. Functional response to beta-blocker therapy was assigned as a stable or improved LVEF or diminished LVEF. Sixteen patients were included (age 47.9 +/- A 11.5 years; 12 males, LVEF 28.6 +/- A 8.4%). Seven patients showed improved LVEF (9.7 +/- A 3.1%), and nine patients did not show improved LVEF (-3.4 +/- A 3.9%). MPR improved significantly in responders (1.56 +/- A .23 to 1.93 +/- A .49, P = .049), and MPR decreased in non-responders; however, not significantly (1.98 +/- A .70 to 1.61 +/- A .28, P = .064), but was significantly different between both groups (P = .017) after beta-blocker therapy. A significant correlation was found between change in perfusion reserve and change in LVEF: a decrease in perfusion reserve was associated with a decrease in LVEF and vice versa. Summed rest score of wall motion in responders improved from 26 to 21 (P = .022) whereas in non-responders no change was observed from 26 to 25) (P = ns). Summed stress score of wall motion in responders improved from 23 to 21 (P = .027) whereas in non-responders no change was observed from 27 to 26) (P = ns). In IDC patients, global as well as regional improvement after initiation of beta-blocker treatment is accompanied by an improvement in regional perfusion parameters. On the other hand in IDC patients with further left ventricular function deterioration after initiation of beta-blocker therapy this is accompanied by a decrease in perfusion reserve.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 50 条
  • [41] Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
    Hu, Mengjin
    Hu, Song
    Gao, Xiaojin
    Yang, Yuejin
    MEDICINA-LITHUANIA, 2022, 58 (09):
  • [42] Effect of Beta-Blocker Therapy on Survival in Patients With Severe Aortic Regurgitation Results From a Cohort of 756 Patients
    Sampat, Unnati
    Varadarajan, Padmini
    Turk, Rami
    Kamath, Ashvin
    Khandhar, Sumit
    Pai, Ramdas G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (05) : 452 - 457
  • [43] Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
    Ahn, Min-Soo
    Yoo, Byung-Su
    Son, Jung-Woo
    Yu, Min Heui
    Kang, Dae Ryong
    Lee, Hae-Young
    Jeon, Eun-Seok
    Kim, Jae-Joong
    Chae, Shung Chull
    Baek, Sang Hong
    Kang, Seok-Min
    Choi, Dong-Ju
    Kim, Kye Hun
    Cho, Myeong-Chan
    Kim, Seong Yoon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (33)
  • [44] A Blunted Heart Rate Response During Dobutamine Stress Echocardiography is Associated with Impaired Myocardial Contractile Reserve in Dilated Cardiomyopathy
    Ciampi, Quirino
    Pratali, Lorenza
    Cortigiani, Lauro
    Manicardi, Chiara
    Villari, Bruno
    Picano, Eugenio
    Sicari, Rosa
    CIRCULATION, 2012, 126 (21)
  • [45] Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy
    Raimoglou, Damla
    Izgi, Cemil
    Enar, Rasim
    Karpuz, M. Hakan
    Karadag, Bilgehan
    Ikitimur, Baris
    Raimoglu, Utku
    Soysal, Ali Ugur
    Kargin, O. Aykan
    Gueven, Mehmet
    Malikova, Namina
    Citak, Elif
    Yurtseven, Ece
    Durmaz, Eser
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (03) : 150 - 157
  • [46] Prognostic value of summed motion score assessed by gated SPECT myocardial perfusion imaging in patients with dilated cardiomyopathy
    Zhu, Jun-Yan
    Wang, Xin-Chao
    Huang, Nan
    Li, Xiao-Qian
    Cheng, Yan
    Wu, Zhi-Fang
    Li, Yuan-Yuan
    Wu, Ping
    Li, Li
    Wei, Hua
    Li, Si-Jin
    Cao, Ji-Min
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [47] Clinical and functional effects of beta-blocker therapy discontinuation in patients with biventricular heart failure
    Slavich, Massimo
    Ricchetti, Gianluca
    Demarchi, Barbara
    Cavalli, Giulio
    Spoladore, Roberto
    Federico, Anna
    Federico, Francesco
    Bezzi, Carolina
    Margonato, Alberto
    Fragasso, Gabriele
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (02) : 141 - 148
  • [48] Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy
    de Jong, RM
    Cornel, JH
    Crijns, HJGM
    van Veldhuisen, DJ
    EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) : 429 - 436
  • [49] Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction: is 50 the new 40?
    Yndigegn, Troels
    Jernberg, Tomas
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (06) : 483 - 485
  • [50] Clinical Outcomes With Beta-Blocker Use in Patients With Recent History of Myocardial Infarction
    Jackevicius, Cynthia A.
    Krumholz, Harlan M.
    Ross, Joseph S.
    Koh, Maria
    Chong, Alice
    Austin, Peter C.
    Stukel, Therese A.
    Azizi, Paymon
    Ko, Dennis T.
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (10) : 1633 - 1640